Fig. 3From: Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinomaOverall survival: group 1 (cTACE) vs. group 2 (DEB-TACE), differentiated by Child stages A and B/C. P-values were 0.4 for Child A and 0.53 for Child B/C patients. “I” denotes censored valuesBack to article page